Cancer on survival survival rate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Prostate Cells, Cultured Lymph Nodes Tumor Cells, Cultured Cell Line Neoplastic Stem Cells

Organisms6

Mice, Nude Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout Mice, Transgenic Mice, SCID

Diseases52

Breast Neoplasms Lung Neoplasms Prostatic Neoplasms Neoplasms Neoplasm Recurrence, Local Neoplasm Metastasis Ovarian Neoplasms Stomach Neoplasms Adenocarcinoma Neoplasm Invasiveness Colorectal Neoplasms Liver Neoplasms Pancreatic Neoplasms Disease Progression Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Rectal Neoplasms Urinary Bladder Neoplasms Colonic Neoplasms Lymphatic Metastasis Carcinoma Esophageal Neoplasms Brain Neoplasms Carcinoma, Hepatocellular Genetic Predisposition to Disease Recurrence Bone Neoplasms Disease Models, Animal Postoperative Complications Head and Neck Neoplasms Melanoma Carcinoma, Small Cell Kidney Neoplasms Uterine Cervical Neoplasms Skin Neoplasms Mouth Neoplasms Endometrial Neoplasms Sarcoma Bile Duct Neoplasms Glioblastoma Cell Transformation, Neoplastic Cholangiocarcinoma Heart Arrest Neoplasms, Second Primary Carcinoma, Pancreatic Ductal Peritoneal Neoplasms Kidney Failure, Chronic Neovascularization, Pathologic Gastrointestinal Neoplasms Multiple Myeloma Glioma Out-of-Hospital Cardiac Arrest

Chemicals and Drugs46

Tumor Markers, Biological Antineoplastic Agents Cisplatin Prostate-Specific Antigen Fluorouracil Neoplasm Proteins Cyclophosphamide RNA, Messenger Androgen Antagonists Receptor, erbB-2 Cancer Vaccines Tumor Suppressor Protein p53 Receptors, Estrogen Vincristine Deoxycytidine Antimetabolites, Antineoplastic Doxorubicin Paclitaxel Antibodies, Monoclonal RNA, Small Interfering Antineoplastic Agents, Phytogenic DNA, Neoplasm Proto-Oncogene Proteins Etoposide Antineoplastic Agents, Hormonal Tamoxifen Taxoids Receptors, Progesterone Prednisone Receptor, Epidermal Growth Factor Carboplatin Vinblastine Antibodies, Monoclonal, Humanized Antigens, Neoplasm Methotrexate Organoplatinum Compounds DNA-Binding Proteins Leucovorin Tumor Suppressor Proteins Immunosuppressive Agents Phosphatidylinositol 3-Kinases Camptothecin Protein-Serine-Threonine Kinases Transcription Factors Protein Kinase Inhibitors Enzyme Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment92

Survival Rate Survival Analysis Disease-Free Survival Retrospective Studies Treatment Outcome Prognosis Neoplasm Staging Follow-Up Studies Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Proportional Hazards Models Early Detection of Cancer Prospective Studies Risk Factors Multivariate Analysis Risk Assessment Cohort Studies Chemotherapy, Adjuvant Registries Immunohistochemistry Predictive Value of Tests Incidence Prostatectomy Radiotherapy, Adjuvant Biopsy Actuarial Analysis SEER Program Reverse Transcriptase Polymerase Chain Reaction Chi-Square Distribution Sensitivity and Specificity Drug Administration Schedule Logistic Models Risk Gene Expression Profiling Biopsy, Needle Liver Transplantation Disease Models, Animal Life Tables Blotting, Western Lymph Node Excision Reproducibility of Results Radiotherapy Radiotherapy Dosage Clinical Trials as Topic Tomography, X-Ray Computed Questionnaires Cause of Death Palliative Care Neoplasm Transplantation Xenograft Model Antitumor Assays Neoplasm Grading Remission Induction Tumor Burden Probability Hepatectomy Gastrectomy Odds Ratio Case-Control Studies Analysis of Variance Tissue Array Analysis Reoperation Oligonucleotide Array Sequence Analysis Cardiopulmonary Resuscitation Transplantation, Homologous Models, Biological Kidney Transplantation Patient Selection Regression Analysis Transplantation, Heterologous Salvage Therapy Pneumonectomy Polymerase Chain Reaction Immunoenzyme Techniques Chemoradiotherapy Esophagectomy Treatment Failure Neoadjuvant Therapy Confidence Intervals Transfection Dose-Response Relationship, Radiation Mastectomy Severity of Illness Index Immunotherapy Molecular Targeted Therapy Statistics, Nonparametric Preoperative Care Chemoembolization, Therapeutic Clinical Trials, Phase III as Topic Infusions, Intravenous Dose Fractionation Gene Knockdown Techniques

Psychiatry and Psychology1

Phenomena and Processes37

Cell Survival Graft Survival Time Factors Apoptosis Gene Expression Regulation, Neoplastic Mutation Chi-Square Distribution Signal Transduction Sensitivity and Specificity Cell Proliferation Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Dose-Response Relationship, Drug Probability Cell Division Odds Ratio Genotype Graft Rejection Cell Movement Up-Regulation Down-Regulation Cell Cycle Phosphorylation Phenotype Gene Expression Longevity Cell Death Transfection Dose-Response Relationship, Radiation DNA Methylation RNA Interference Cell Differentiation Microbial Viability Polymorphism, Genetic Base Sequence Promoter Regions, Genetic

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena5

Survival Quality of Life National Cancer Institute (U.S.)Cost of Illness Age Distribution

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Incidence SEER Program Life Tables Questionnaires Cause of Death Molecular Sequence Data Base Sequence

Named Groups4

Survivors Tissue Donors Infant, Newborn European Continental Ancestry Group

Health Care47

Survival Rate Survival Analysis Disease-Free Survival Retrospective Studies Treatment Outcome Follow-Up Studies Kaplan-Meier Estimate Proportional Hazards Models Prospective Studies Risk Factors Multivariate Analysis Age Factors Risk Assessment Cohort Studies Registries Predictive Value of Tests Incidence Actuarial Analysis SEER Program Chi-Square Distribution Sensitivity and Specificity Logistic Models Risk Life Tables Reproducibility of Results Clinical Trials as Topic Questionnaires Cause of Death Palliative Care Probability Odds Ratio Sex Factors Case-Control Studies Analysis of Variance Patient Selection Regression Analysis Treatment Failure National Cancer Institute (U.S.)Confidence Intervals Dose-Response Relationship, Radiation Cost of Illness Age Distribution Severity of Illness Index Comorbidity Statistics, Nonparametric Preoperative Care Clinical Trials, Phase III as Topic

Geographicals5

United States Japan China Europe Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Survival Analysis Disease-Free Survival Survival Retrospective Studies Treatment Outcome Prognosis Neoplasm Staging Follow-Up Studies Breast Neoplasms Graft Survival Lung Neoplasms Kaplan-Meier Estimate Prostatic Neoplasms Time Factors Neoplasms Antineoplastic Combined Chemotherapy Protocols Neoplasm Recurrence, Local Combined Modality Therapy Proportional Hazards Models Neoplasm Metastasis Early Detection of Cancer Prospective Studies Tumor Markers, Biological Ovarian Neoplasms Stomach Neoplasms Risk Factors Adenocarcinoma Antineoplastic Agents Neoplasm Invasiveness Multivariate Analysis Age Factors Colorectal Neoplasms Survivors Cisplatin Risk Assessment Cohort Studies Chemotherapy, Adjuvant Liver Neoplasms Pancreatic Neoplasms Cell Line, Tumor Registries Disease Progression Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Apoptosis Rectal Neoplasms Immunohistochemistry Urinary Bladder Neoplasms Prostate-Specific Antigen Colonic Neoplasms Lymphatic Metastasis Predictive Value of Tests Gene Expression Regulation, Neoplastic United States Carcinoma Quality of Life Incidence Fluorouracil Prostatectomy Radiotherapy, Adjuvant Biopsy Actuarial Analysis Esophageal Neoplasms Mutation Mice, Nude Neoplasm Proteins SEER Program Brain Neoplasms Reverse Transcriptase Polymerase Chain Reaction Chi-Square Distribution Signal Transduction Sensitivity and Specificity Drug Administration Schedule Cell Proliferation Cyclophosphamide Carcinoma, Hepatocellular Genetic Predisposition to Disease Recurrence Drug Resistance, Neoplasm RNA, Messenger Prostate Logistic Models Risk Gene Expression Profiling Bone Neoplasms Biopsy, Needle Androgen Antagonists Dose-Response Relationship, Drug Liver Transplantation Disease Models, Animal Life Tables Blotting, Western Postoperative Complications Lymph Node Excision Reproducibility of Results Radiotherapy Head and Neck Neoplasms Receptor, erbB-2

No FAQ available that match "cancer on survival survival rate"